Connecting Men, Families, Doctors, and other Medical Professionals to Clinical Trials for Prostate Cancer

        Inclusion Criteria:

          -  18 years or older.

          -  Raising PSA after prior treatment failure of localized prostate cancer.

          -  Has a histological confirmed non-metastatic cancer of the prostate (Gleason graded)
             based on the most current biopsy.

          -  Has a screening testosterone with-in normal range >=1.5 ng/mL.

          -  Has ECOG score of <=2.

          -  CT scan, MRI or bone scan report documenting no evidence of metastasis to the bone or
             internal organs.

          -  Life expectancy of at least 15 months.

        Exclusion Criteria:

          -  Taken hormone therapy in the last 6 months prior to entering this study.

          -  Has a history of sever uncontrolled asthma, anaphylactic reactions, or sever
             urticaria and/or angioedema.

          -  Has hypersensitivity towards any component of the study drug.

          -  Has a previous history or presence of another malignancy other than prostate cancer
             or treated squamous/basel cell carcinoma of the skin within the last five years.

          -  Abnormal laboratory results which in the judgement of the Investigator would affect
             the patient's health or the outcome of the trial.

          -  Has a clinically significant medical condition (other than prostate cancer) including
             but not limited to; renal, haematological, gastrointestinal, endocrine, cardiac,
             neurological or psychiatric disease and alcohol or drug abuse or any other condition
             which may affect the patient's health or the outcome of the trial as judged by the
             Investigator.

          -  Has an intellectual incapacity or language barriers precluding adequate understanding
             or co-operation.

          -  Has received an investigational drug within the last 28 days before the Screening
             visit or longer if considered to possibly influence the outcome of the current trial.

          -  Has previously participated in any Degarelix trial.

          -  Is part of an ongoing trial.